University of Michigan

Daniel Klionsky

Alexander G. Ruthven Professor of Life Sciences28 Sept 2026lsi.umich.edu

NCT07594145

CollaboratorPhase 2Not yet recruiting202657 people18 May 2026clinicaltrials.gov

NCT07515664

Phase 4Recruiting202520 people7 Apr 2026clinicaltrials.gov

NCT07091734

Phase 2Recruiting202532 people29 Jul 2025clinicaltrials.gov

NCT06785116

Phase 4Recruiting2025200 people21 Jan 2025clinicaltrials.gov

NCT06671002

Phase 4Recruiting2025900 people4 Nov 2024clinicaltrials.gov

NCT06291155

Phase 4Recruiting202420 people4 Mar 2024clinicaltrials.gov

NCT06226025

CollaboratorPhase 2Recruiting202450 people26 Jan 2024clinicaltrials.gov

NCT06217302

CollaboratorPhase 3Recruiting2024150 people22 Jan 2024clinicaltrials.gov

NCT05832229

CollaboratorPhase 2Recruiting2023260 people27 Apr 2023clinicaltrials.gov

NCT05507892

CollaboratorPhase 2Active, not recruiting202245 people19 Aug 2022clinicaltrials.gov

The Lifestyle Education About Prediabetes (Leap) Study

No phaseCompleted2022304 people11 Feb 2022clinicaltrials.gov

NCT05195918

CollaboratorPhase 1Completed202350 people19 Jan 2022clinicaltrials.gov

NCT04929379

CollaboratorPhase 2Active, not recruiting202240 people18 Jun 2021clinicaltrials.gov

Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation

Phase 4Completed2021117 people12 Nov 2020clinicaltrials.gov

NCT04403399

Phase 2Completed201734 people27 May 2020clinicaltrials.gov

NCT04300920

CollaboratorPhase 3Completed2020202 people9 Mar 2020clinicaltrials.gov

NCT03829046

CollaboratorPhase 4Completed201941 people4 Feb 2019clinicaltrials.gov

NCT03715465

Phase 3Completed201944 people23 Oct 2018clinicaltrials.gov

NCT03575572

Phase 2/3Terminated201811 people2 Jul 2018clinicaltrials.gov

NCT03489629

CollaboratorPhase 2Completed201849 people5 Apr 2018clinicaltrials.gov